Introduction {#Sec1}
============

Intracellular pathogens invade, survive and replicate in mammalian cells, modulating host-cell membrane trafficking and cytoskeletal dynamics in order to establish persistent infection in the mammalian host \[[@CR1]--[@CR3]\]. Macrophages are a frequent target of microbial infections, and they respond to microbial invasion by producing factors such as reactive nitrogen and oxygen intermediates (RNIs and ROIs) that have strong microbicidal activity \[[@CR4]\]. But many pathogens have evolved different strategies for avoiding destruction by the macrophage. Some intracellular pathogens, such as *Mycobacteria*, inhabit a compartment whose endocytic maturation is delayed, while *Chlamydiae* survive within a membrane-bound vacuole that avoids fusion with lysosomes and maintains a neutral pH \[[@CR5], [@CR6]\]. Unlike *Mycobacteria* and *Chlamydia*, the protozoan parasite *Leishmania* thrives in a parasitophorous vacuole that has an acidic pH and high hydrolytic activity, and *Trypanosoma cruzi* actively induces its uptake into lysosome-like host-cell vacuoles, from which, the parasite rapidly escapes into the cytosol \[[@CR7]--[@CR10]\].

At the end of their infection cycle, each of these intracellular parasites is released from the host cell, triggering macrophage death and inducing local inflammation, accompanied by the possible release of ATP, as shown for macrophages infected with *Mycobacterium tuberculosis* \[[@CR11]\]. As extracellular ATP (ATP~e~) can be used by neighbouring macrophages as ammunition to inhibit infection (described below), many intracellular pathogens such as *Mycobacterium bovis* BCG, *Vibrio cholerae*, *M. tuberculosis*, *T. cruzi* and *Leishmania* also secrete or express on their outer surface enzymes that degrade or synthesise nucleotides \[[@CR12]--[@CR15]\]; and microbial enzymes that consume or produce ATP are considered as virulence factors for *M. tuberculosis*, *Leishmania amazonensis* and *T. cruzi* \[[@CR14], [@CR16]--[@CR18]\].

Macrophages activate microbicidal pathways and contribute to inflammation after the ligation of purinergic P2 receptors by ATP~e~. This review will, therefore, describe some of the P2-dependent mechanisms used by macrophages to eliminate infection by intracellular bacteria and protozoan parasites, and, whenever possible, will correlate these findings with host susceptibility and resistance to infection.

Effect of ATP~e~ on macrophage infection by ***M. tuberculosis*** {#Sec2}
=================================================================

The first evidence for an involvement of ATP~e~ in the control of intracellular infections came from the laboratory of Kaplan, who demonstrated in 1994, that ATP~e~-mediated apoptosis in *Mycobacterium tuberculosis*-infected macrophages is associated with the inhibition of mycobacterial infection \[[@CR19]\]. This early study also showed that ATP~e~-induced macrophage apoptosis, but not H~2~O~2~-induced necrosis, is associated with the killing of the intracellular mycobacteria. These findings were confirmed by Lammas et al., who proposed that the ATP~e~-induced elimination of BCG-infected human macrophages are mediated by the purinergic receptor, P2X~7~, through a mechanism independent of both RNIs and ROIs \[[@CR20]\]. In comparison with other ligands that can trigger the lysis of macrophages, including complement-mediated cytolysis, Fas ligation and CD69 activation, only ATP~e~ treatment could stimulate the death of both host macrophages and intracellular mycobacteria. Subsequently, several laboratories confirmed that the P2X~7~ receptor plays a role in limiting infection in murine and bovine macrophages infected with mycobacteria, and in human macrophages infected with BCG bacillus and virulent strains of *M. tuberculosis* \[[@CR11], [@CR21]--[@CR23]\].

In addition to the P2X~7~ receptor, other P2 receptor subtypes, possibly P2Y, are apparently involved in ATP~e~-mediated bactericidal activity in macrophages \[[@CR11], [@CR21], [@CR23]\]. Experiments using macrophages derived from P2X~7~-deficient mice revealed that ATP~e~ stimulates the production of reactive species such as RNIs equally well in both wildtype and P2X~7~-deficient macrophages \[[@CR11]\]. Moreover, it was found that ATP~e~ induces bactericidal effects in the macrophages better than BzATP (the most potent known agonist for the P2X~7~ receptor), suggesting that P2X~7~ receptors are necessary, but not sufficient, for maximal ATP~e~-dependent killing of intracellular *M. tuberculosis* by human and bovine macrophages \[[@CR21], [@CR22]\]. Lammas et al. have further observed that the ATP~e~ activity is potentiated by extracellular Zn^2+^ \[[@CR20]\]. This effect was initially ascribed to the P2X~7~ receptor, but now, P2X~7~ activity is known to be blocked by extracellular Zn^2+^, while the activity of another purinergic receptor, P2X~4~, is potentiated by Zn^2+^ \[[@CR24]\]. Since macrophages express functional P2X~4~ receptors \[[@CR25]\] and inflammatory mediators can upregulate this receptor on macrophages \[[@CR26]\], it is likely that both P2X~7~ and P2X~4~ are involved in the ATP~e~-induced killing of *M. tuberculosis* in macrophages.

More recent reports have also confirmed the predominant role of the P2X~7~ receptor in mycobacterial clearance, extending these results to show that loss-of-function polymorphisms in human P2X~7~ receptors lead not only to reduced ATP~e~-induced apoptosis, but also to impaired ATP~e~-induced killing of intracellular mycobacteria (BCG) by macrophages \[[@CR27]--[@CR29]\]. Nonetheless, more experiments will be required to elucidate the role that P2X~7~, possibly in conjunction with other P2 receptors, may play in the killing of intracellular mycobacteria in vivo, since P2X~7~-deficient mice control lung infection as well as wildtype mice after low-dose aerosol infection with virulent *M. tuberculosis* \[[@CR30]\].

Cellular mechanisms of ATP~e~-induced mycobacterial killing {#Sec3}
===========================================================

ATP~e~ ligation of P2X~7~ on macrophages results in a variety of different cellular effects, including the activation of phospholipase D (PLD), maturation and release of interleukin-1β (IL-1β), generation of macrophage polykarions, modulation of lipopolysaccharide (LPS) induced macrophage activation through modulation of iNOS expression and NO production, and the induction of macrophage death by necrosis and/or apoptosis \[[@CR31]--[@CR40]\]. The original findings from the Kaplan laboratory suggested that the apoptosis of macrophages is necessary for ATP~e~-mediated killing of intracellular bacteria \[[@CR19]\], but it was later established that the ATP~e~-induced killing of mycobacteria in human and mice macrophages can occur without macrophage death, through a pathway requiring PLD activation, the acidification of phagosomes and phagosome--lysosome fusion \[[@CR21]\] (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR23], [@CR41]\]. A more recent study showed that, when combined, two loss-of-function polymorphisms in human P2X~7~ receptors impair ATP~e~-mediated apoptosis, despite the normal killing of BCG bacillus \[[@CR28]\], reinforcing the view that the apoptosis of macrophages is not necessary for the elimination of mycobacteria. Fig. 1ATP released from infected cells undergoing necrosis or sites of inflammation can bind to the P2X~7~ receptor on neighbouring macrophages and other cells. Ligation of the P2X~7~ receptor initiates signalling through several pathways, which result in the activation of caspase-1, activation of phospholipase D (PLD) and, ultimately, cell death. Caspase-1 activation stimulates the inflammatory response by the cleavage of pro-IL-1β and secretion of the mature cytokine. PLD activation modifies membrane trafficking in the cell, which can induce fusion between lysosomes and vacuoles, harbouring intracellular pathogens such as mycobacteria and chlamydiae. The death of macrophages is partly necrotic, which may amplify inflammation even further, through the ligation of P2X~7~ receptors on other cells. Some extracellular ATP may also bind to other P2 receptors, which may inhibit infection by activating as-yet-uncharacterised pathways

In fact, it was recently shown \[[@CR42]\] that cyclosporine A, an inhibitor of the mitochondrial permeability transition, increases the survival of human monocyte-derived macrophages infected with *M. tuberculosis*, restores P2X~7~ function and enhances antimycobacterial activity. Conversely, *M. tuberculosis* has developed mechanisms to evade P2X~7~-triggered mechanisms, since it can secrete a nucleoside diphosphate kinase that produces ATP and kills macrophages through a P2X~7~-dependent mechanism \[[@CR14]\]. New experiments are needed to clarify the role played by ATP~e~ in killing intracellular pathogens and inducing host-cell death.

Inhibition of chlamydial infection in macrophages {#Sec4}
=================================================

The *Chlamydia* species are obligate intracellular bacteria that infect mainly epithelial mucosa, where they survive within intracellular vacuoles that avoid fusion with host-cell lysosomes \[[@CR6], [@CR43]\]. Different strains of *C. trachomatis* are responsible for the infection of genital and ocular tissue in humans \[[@CR44]--[@CR48]\]. *C. pneumoniae* is a common cause of community-acquired pneumonia in humans and is associated with an increased risk for atherosclerosis \[[@CR44], [@CR49]\]. Both *C. trachomatis* and *C. pneumoniae* can invade epithelial cells and macrophages in vitro and in vivo \[[@CR49], [@CR50]\].

It was recently shown that ATP~e~ inhibits the infection of macrophages by the murine species of *C. trachomatis*, *C. muridarum*, through a mechanism that required PLD activation and fusion between lysosomes and the *Chlamydia* vacuoles \[[@CR51]\]. The effect of ATP~e~ was dependent on the presence of the P2X~7~ receptor, since there was no PLD activation nor killing of chlamydiae in infected macrophages that had been isolated from P2X~7~-deficient mice. Although P2X~7~ ligation also led to macrophage death, the inhibition of PLD prevented chlamydial killing but had no effect on macrophage death, suggesting that PLD activation was directly responsible for the inhibition of chlamydial infection (Table [1](#Tab1){ref-type="table"}). Moreover, fusion between lysosomes and chlamydial vacuoles preceded macrophage death, further strengthening the conclusion that the killing of chlamydiae is independent of host-cell death \[[@CR51]\]. Table 1Effect of extracellular ATP on intracellular pathogensCell typePathogenEffect describedP2 receptor subtype involvedReferencesHuman macrophagesBCG--Mycobacterial clearanceNot determined\[[@CR19]\]Human macrophagesBCG--Mycobacterial clearanceP2X~7~, P2Y\[[@CR20]\], \[[@CR23]\]BCG--*M. tuberculosis* H37Ra--Acidification of mycobacteria-containing phagosomes\
--Inhibition of P2X~7~-associated permeabilsationP2X~7~\[[@CR42]\]Mouse macrophageBCGProduction of NO and ROIP2Y(?)\[[@CR11]\]Human macrophages*M. tuberculosis* (H37Rv, Erdman and CSU\#93)Mycobacterial clearance; PLD activationP2X~7~+P2(?)\[[@CR21]\]Mouse macrophages and J774 cell lineBCGMycobacterial clearance, PLD activation, phagosome--lysosome fusionP2X~7~\[[@CR41]\]Bovine macrophagesBCGMycobacterial clearance, increase P2X~7~ mRNAP2X~7~\[[@CR22]\]J774 macrophage*C. caviae*--Chlamydial clearance\
--Inhibition of P2X~7~-mediated apoptosisP2X~7~\[[@CR52]\]Mouse macrophages*C. trachomatis*Chlamydial clearance, PLD activation, phagosome--lysosome fusionP2X~7~\[[@CR51]\]Mouse thymocytes*T. cruzi*Modulation of thymocyte deathP2X~7~ (?)\[[@CR64]\]Mouse macrophages*T. cruzi*Inhibition of P2X~7~-mediated permeabilisationP2X~7~\[[@CR65]\]Mouse macrophages*L. amazonensis*; *L. donovani*Increase of P2X~7~-mediated permeabilisationP2X~7~\[[@CR54]\]PLD=phospholipase D; ROI=reactive oxygen intermediates

Conversely, as the activation of P2X~7~-dependent pathways is deleterious for *Chlamydia*, both directly and through the demise of the macrophage, the intracellular pathogen has also evolved a mechanism for protecting its host cell. Thus, the infection of macrophages with a related species, *C. psittaci* (also known as *C. caviae*), inhibits partially ATP~e~-mediated macrophage death \[[@CR52]\]. While the molecular basis for host-cell protection remains to be investigated, chlamydial infection decreases partially the ability of ATP~e~ to induce plasma--membrane permeabilisation and calcium fluxes \[[@CR52]\]. Chlamydiae, therefore, resemble other pathogenic bacteria and protozoan parasites that attempt to protect themselves and the host cell by degrading nucleotides or hydrolysing ATP.

Effects of ATP~e~ on leishmaniasis {#Sec5}
==================================

Leishmaniasis is used to describe several diseases caused by the obligate intracellular protozoan parasite *Leishmania*, which infects mainly macrophages \[[@CR53]\]. The diseases range from self-healing cutaneous lesions to visceral and potentially fatal disseminating infection. *Leishmania* infections are found in 80 countries, with a prevalence of 12 million human cases. The development of different clinical forms is associated with both the immunological status of the host and the parasite species \[[@CR53]\]. The expression of the P2X~7~ receptor has recently been examined during *Leishmania* infection, revealing upregulation of the receptor during both in vivo and in vitro infection with *L. amazonensis* \[[@CR54]\]. These changes were correlated with functional responses, as reflected by an increase in ATP~e~-mediated plasma--membrane permeabilisation and host-cell apoptosis (\[[@CR54]\] and Chaves et al. (manuscript in preparation)) (Table [1](#Tab1){ref-type="table"}). The increase in ATP~e~-induced membrane permeabilisation was also observed in spleen macrophages isolated from mice infected with *L. donovani*, suggesting that this may be a general phenomenon relevant for all *Leishmania* infections.

It has been proposed that intracellular infection by *Leishmania donovani* inhibits macrophage apoptosis induced by growth factor deprivation \[[@CR55]\]. In contrast, there is an increase in the ATP~e~-mediated apoptosis of macrophages infected with *Leishmania* (our unpublished data), consistent with the increases in ATP~e~-mediated membrane permeabilisation. Thus, despite the production of ecto-ATPases by *Leishmania* \[[@CR16]\], this strategy is not sufficient to protect the host cell against the infection-dependent upregulation in P2X~7~ expression.

We have observed that the presence of ATP~e~ during *L. amazonensis* infection does not interfere with *Leishmania* invasion, but the ATP~e~ treatment of macrophages that are already infected with *L. amazonensi* leads to a decrease in *Leishmania* survival (our unpublished observations). In addition, we observed that ATP~e~ has no effect on the viability of extracellular *Leishmania* promastigotes. In fact, some nucleotides, such as UTP, stimulate the proliferation of promastigotes. It is also worthwhile noting that the more infective forms of *L. amazonensis* express more magnesium-dependent ecto-ATPase on their membranes than less virulent *Leishmania*, leading to the proposal that the ecto-ATPase should be viewed as a virulence factor of the parasite \[[@CR16]\].

The cellular pathway allowing ATP~e~ to decrease *Leishmania* infection remains to be determined, but must be different from the PLD activation observed during *Chlamydia* and *Mycobacterium* infection \[[@CR41], [@CR51]\], since both *Chlamydia* and *Mycobacterium* inhibit phagolysosome formation and acidification \[[@CR4], [@CR6], [@CR8]\], while *Leishmania* survives well in acidic phagolysosomes \[[@CR56]\]. Interestingly, *Leishmania* lipophosphoglycans, which promote parasite survival, act by perturbing MAPKinase signalling in macrophages to inhibit macrophage IL-1β \[[@CR57]\]. This might be relevant for the involvement of P2 receptors in the escape mechanisms used by *Leishmania*, since several P2 receptors are connected to MAPKinase pathways \[[@CR58]\].

The involvement of ATP~e~ in Chagas--disease {#Sec6}
============================================

Chagas--disease is caused by the facultative intracellular protozoan pathogen, *T. cruzi*. The disease is a chronic inflammatory condition characterised by cardiomyopathy and digestive disorders \[[@CR59], [@CR60]\]. *T. cruzi* infection affects over 17 million people in endemic areas of Latin America, leading to 45 thousand deaths per year \[[@CR61]\]. The involvement of ATP~e~ signalling was recently examined during the acute phase of *T. cruzi* infection. Thymus atrophy occurs during the acute phase of infection but the thymus recovers weight and cellularity during the chronic phase \[[@CR62]\]. These alterations do not appear to be associated with stress or glucocorticoid release \[[@CR63]\]. It has recently been observed that thymocytes are sensitive to ATP~e~-induced membrane permeabilisation and host-cell death only during the atrophy phase of infection, with CD4^+^/CD8^+^ double-positive thymocytes being the most sensitive subpopulation of thymocytes \[[@CR64]\] (Table [1](#Tab1){ref-type="table"}). Since the phenomenon of ATP-induced permeabilisation can be blocked by the P2X~7~ inhibitors, oxidised ATP and Mg^2+^, and the P2X~7~ agonist, BzATP, was more potent than ATP, we proposed that the increased sensitivity to ATP~e~ may be responsible, at least in part, for the thymocyte clearance and thymic atrophy observed during the acute phase of Chagas's disease \[[@CR64]\].

It is, therefore, reasonable to suppose that ATP~e~ plays an important role in the *T. cruzi* infection cycle. In this context, it is worth noting that the ecto-ATPases produced by these parasites have been associated with strain virulence \[[@CR17]\].

P2X~7~ receptors and inflammation {#Sec7}
=================================

The stimulation of P2X~7~ by ATP~e~ leads to caspase-1 activation, cleavage of pro-IL-1β and the secretion of mature IL-1β \[[@CR66]\] (Fig. [1](#Fig1){ref-type="fig"}). The P2X~7~ receptor is also upregulated in macrophages by inflammatory cytokines, such as interferon-γ (IFN-γ) and tumour necrosis factor-α (TNF-α), and lipopolysaccharide (LPS). LPS, a surface component of most Gram-negative bacteria, and IFN-γ act synergistically to upregulate P2X~7~ receptor function and P2X~7~ mRNA in the human monocyte cell line, THP-1, and human macrophages \[[@CR34], [@CR37]\]. In fact, P2X~7~ receptors contain several motifs that are homologous to motifs from other receptors known to be involved in protein--protein interactions and LPS binding \[[@CR67]\]. The upregulation of P2X~7~ expression in monocytes by TNF-α, LPS and IFN-γ is consistent with the ability of these cytokines to act as inflammatory mediators, and these effects are markedly attenuated by coincubation with prostaglandin E2 (PGE~2~) or the membrane-permeable cAMP analogue, dibutyril cAMP \[[@CR68]\]. It is tempting to speculate that the temporal sequence of macrophage exposure to pro-inflammatory activators and anti-inflammatory stimuli (such as PGE~2~) might regulate not only receptor expression, but also downstream signalling by the P2X~7~ receptors.

It is known that macrophages express adenosine receptors, which are expressed during the differentiation of monocytes to macrophages and may influence phagocytosis \[[@CR69]\]. Moreover, the treatment of macrophages with IFN-γ upregulates expression of the adenosine receptor, A~2B~, and the activation of A~2B~ receptors is involved with the deactivation of macrophages, possibly through an increase of cAMP \[[@CR70]\]. Therefore, the extracellular nucleotides may be involved with activation and a feedback mechanism for macrophage deactivation, depending on the timing and type of nucleotide released during infection. In this context, \\studies with P2X~7~-deficient mice have reinforced the view that P2X~7~ receptors are involved in inflammation. Thus, disruption of the P2X~7~ receptor gene is associated with less severe disease in an arthritis model \[[@CR71]\] and studies of chronic inflammation and neuropathic pain \[[@CR72]\]. These results led to the hypothesis that the P2X~7~ receptor, through the regulation of IL-1β production and secretion, plays a common, early role in the development of pain of neuropathic and inflammatory origin \[[@CR71], [@CR72]\]. Additionally, a recent study demonstrates that the inhibition of the P2X~7~ receptor attenuates fever and cytokine responses induced by LPS in rats \[[@CR73]\]. Finally, the P2X~7~ receptor is present and its expression is modulated by inflammation in sites of chronic inflammation \[[@CR74]\].

All of these findings reinforce the conclusion that P2X~7~-dependent signalling plays a significant role in host responses during various types of inflammatory disease. However, the involvement of P2X~7~ during disease is complicated by the presence of other P2 receptors, which may also contribute to either pro- or anti-inflammatory immune responses. Moreover, ATP can negatively regulate Toll-like receptor signalling, suppress LPS-induced MCP-1 and TNF-α, and augments IL-10 production in human monocytes \[[@CR75]\]. Many infectious agents that survive in these immune effector cells may have evolved complex nucleotide-based strategies to evade the immune system. Dissection of these strategies may lead us to a better understanding of the role of nucleotide signalling in the immune response and to the development of new approaches to combat infectious diseases.

Concluding remarks {#Sec8}
==================

As large concentrations of ATP are present outside of the cell only when the cell is damaged or is part of an inflamed tissue (Fig. [1](#Fig1){ref-type="fig"}), it has been proposed that ATP~e~ may function as a generic 'danger signal,--which could alert the immune system to the presence of any type of intracellular pathogen that induces host-cell death \[[@CR76]--[@CR78]\]. Different intracellular pathogens, such as bacteria and protozoan parasites, express ecto-ATPases or other mechanisms to either inhibit or enhance ATP~e~-mediated death of their host cell, suggesting that ATP~e~ may have been used by the host as an ancient danger signal, to which, intracellular pathogens have been exposed since the early evolution of the immune system. In this context, the ability of some intracellular pathogens to inhibit the ATP~e~-dependent response mediated by P2 receptors could be an example of adaptation of the pathogenic invaders to the immune response, and may help to explain why the most virulent pathogens express high ecto-ATPase levels on their surface \[[@CR14]--[@CR17]\]. Given the availability of animals that are deficient in P2X~7~ and other P2 receptors, further research in the future will, thus, need to address the relevance of P2-dependent immune mechanisms in controlling infections in whole organisms.
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